Posted in FINANCE Moderna Reports RSV Vaccine Cuts Risk of Respiratory Diseases January 17, 2023 The company said it would apply in coming months for U.S. regulatory approval. https://www.wsj.com/articles/modernas-rsv-vaccine-reduces-risk-of-respiratory-diseases-study-finds-11673986424?mod=pls_whats_news_us_business_f